nct02637284 bpc 157 Multifunctionality and Possible Medical Application of the Peptide—Literature and Patent Review nct02637284 bpc-157 trial and the

*Correspondence: Predrag Sikiric, [email protected] This article was submitted to Gastrointestinal and Hepatic Pharmacology, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

Jiang B-H, Liu L-Z

Cag replicates and extends these effects, giving researchers a uniquely durable compound for studying the central regulation of appetite and metabolic function

Substituting tirzepatide for semaglutide is a theoretical extension of that idea pairing an amylin analog with a more potent dual incretin agonist but it is important to repeat that this specific pairing has not been validated in a dedicated human combination trial